S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Stock market today: Asian world shares mostly lower after Wall St has its worst week in 6 months
Would Buffett Approve of This Growth Strategy? (Ad)
Oil prices have risen. That's making gas more expensive for US drivers and helping Russia's war
3 Blue Chip Safe Havens to Shield Your Portfolio
Would Buffett Approve of This Growth Strategy? (Ad)
Writers Guild and Hollywood studios reach tentative agreement to end strike. No deal yet for actors
AI is on the world's mind. Is the UN the place to figure out what to do about it?
Would Buffett Approve of This Growth Strategy? (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Is Datadog a Buyout Target After Cisco's Splunk Acquisition?
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Stock market today: Asian world shares mostly lower after Wall St has its worst week in 6 months
Would Buffett Approve of This Growth Strategy? (Ad)
Oil prices have risen. That's making gas more expensive for US drivers and helping Russia's war
3 Blue Chip Safe Havens to Shield Your Portfolio
Would Buffett Approve of This Growth Strategy? (Ad)
Writers Guild and Hollywood studios reach tentative agreement to end strike. No deal yet for actors
AI is on the world's mind. Is the UN the place to figure out what to do about it?
Would Buffett Approve of This Growth Strategy? (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Is Datadog a Buyout Target After Cisco's Splunk Acquisition?
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Stock market today: Asian world shares mostly lower after Wall St has its worst week in 6 months
Would Buffett Approve of This Growth Strategy? (Ad)
Oil prices have risen. That's making gas more expensive for US drivers and helping Russia's war
3 Blue Chip Safe Havens to Shield Your Portfolio
Would Buffett Approve of This Growth Strategy? (Ad)
Writers Guild and Hollywood studios reach tentative agreement to end strike. No deal yet for actors
AI is on the world's mind. Is the UN the place to figure out what to do about it?
Would Buffett Approve of This Growth Strategy? (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Is Datadog a Buyout Target After Cisco's Splunk Acquisition?
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Stock market today: Asian world shares mostly lower after Wall St has its worst week in 6 months
Would Buffett Approve of This Growth Strategy? (Ad)
Oil prices have risen. That's making gas more expensive for US drivers and helping Russia's war
3 Blue Chip Safe Havens to Shield Your Portfolio
Would Buffett Approve of This Growth Strategy? (Ad)
Writers Guild and Hollywood studios reach tentative agreement to end strike. No deal yet for actors
AI is on the world's mind. Is the UN the place to figure out what to do about it?
Would Buffett Approve of This Growth Strategy? (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Is Datadog a Buyout Target After Cisco's Splunk Acquisition?
NYSE:TFX

Teleflex (TFX) Competitors

$204.02
+0.56 (+0.28%)
(As of 09/22/2023 08:52 PM ET)
Compare
Today's Range
$201.30
$204.73
50-Day Range
$203.42
$258.85
52-Week Range
$182.65
$276.43
Volume
395,200 shs
Average Volume
307,485 shs
Market Capitalization
$9.59 billion
P/E Ratio
26.19
Dividend Yield
0.67%
Price Target
$268.92

TFX vs. PODD, GMED, IART, BAX, RMD, DXCM, PEN, STVN, SWAV, and INSP

Should you be buying Teleflex stock or one of its competitors? The main competitors of Teleflex include Insulet (PODD), Globus Medical (GMED), Integra LifeSciences (IART), Baxter International (BAX), ResMed (RMD), DexCom (DXCM), Penumbra (PEN), Stevanato Group (STVN), Shockwave Medical (SWAV), and Inspire Medical Systems (INSP). These companies are all part of the "surgical & medical instruments" industry.

Teleflex vs.

Teleflex (NYSE:TFX) and Insulet (NASDAQ:PODD) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, media sentiment, dividends, institutional ownership, community ranking and earnings.

Teleflex has higher revenue and earnings than Insulet. Teleflex is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teleflex$2.79B3.43$363.14M$7.7926.19
Insulet$1.31B8.33$4.60M$0.89174.94

Teleflex has a beta of 1.03, indicating that its share price is 3% more volatile than the S&P 500. Comparatively, Insulet has a beta of 0.81, indicating that its share price is 19% less volatile than the S&P 500.

In the previous week, Teleflex had 4 more articles in the media than Insulet. MarketBeat recorded 7 mentions for Teleflex and 3 mentions for Insulet. Insulet's average media sentiment score of 1.05 beat Teleflex's score of 0.66 indicating that Insulet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Teleflex
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Insulet
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Teleflex currently has a consensus target price of $268.92, suggesting a potential upside of 31.81%. Insulet has a consensus target price of $281.93, suggesting a potential upside of 81.07%. Given Insulet's stronger consensus rating and higher possible upside, analysts plainly believe Insulet is more favorable than Teleflex.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teleflex
0 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.42
Insulet
0 Sell rating(s)
7 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.56

Teleflex has a net margin of 12.71% compared to Insulet's net margin of 4.29%. Insulet's return on equity of 22.42% beat Teleflex's return on equity.

Company Net Margins Return on Equity Return on Assets
Teleflex12.71% 15.48% 9.14%
Insulet 4.29%22.42%4.83%

Insulet received 192 more outperform votes than Teleflex when rated by MarketBeat users. Likewise, 65.94% of users gave Insulet an outperform vote while only 59.65% of users gave Teleflex an outperform vote.

CompanyUnderperformOutperform
TeleflexOutperform Votes
507
59.65%
Underperform Votes
343
40.35%
InsuletOutperform Votes
699
65.94%
Underperform Votes
361
34.06%

97.2% of Teleflex shares are owned by institutional investors. 1.4% of Teleflex shares are owned by company insiders. Comparatively, 0.9% of Insulet shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Teleflex and Insulet tied by winning 9 of the 18 factors compared between the two stocks.


Get Teleflex News Delivered to You Automatically

Sign up to receive the latest news and ratings for TFX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TFX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TFX vs. The Competition

MetricTeleflexSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$9.59B$3.58B$4.48B$15.28B
Dividend Yield0.67%3.55%2.45%3.70%
P/E Ratio26.1957.49114.9421.73
Price / Sales3.4321.842,879.858.69
Price / Cash11.2257.5397.0417.11
Price / Book2.383.523.756.55
Net Income$363.14M$62.03M$122.34M$900.93M
7 Day Performance-4.42%-4.65%-2.59%-2.91%
1 Month Performance-5.12%-8.73%-2.04%-2.65%
1 Year Performance-1.67%-14.14%9.82%8.48%

Teleflex Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PODD
Insulet
2.8972 of 5 stars
$167.38
-2.1%
$281.93
+68.4%
-33.5%$11.69B$1.31B188.072,600Positive News
GMED
Globus Medical
2.6504 of 5 stars
$53.30
+3.3%
$68.22
+28.0%
-12.9%$5.35B$759.12M26.522,600Analyst Revision
IART
Integra LifeSciences
2.339 of 5 stars
$39.27
+0.0%
$47.29
+20.4%
-11.5%$3.20B$1.56B25.013,722
BAX
Baxter International
2.7517 of 5 stars
$38.96
+0.6%
$51.07
+31.1%
-32.0%$19.73B$15.11B-6.8860,000
RMD
ResMed
3.3282 of 5 stars
$143.69
-1.6%
$248.29
+72.8%
-36.3%$21.13B$4.22B23.5610,140Analyst Revision
DXCM
DexCom
3.0841 of 5 stars
$94.16
-1.2%
$136.31
+44.8%
+8.5%$36.52B$2.91B109.497,600
PEN
Penumbra
2.5745 of 5 stars
$262.73
+0.2%
$324.38
+23.5%
+33.8%$10.10B$847.13M355.043,900
STVN
Stevanato Group
2.3023 of 5 stars
€28.57
-5.2%
N/A+62.9%$8.44B$1.04B49.265,260
SWAV
Shockwave Medical
2.8629 of 5 stars
$209.31
-0.9%
$292.29
+39.6%
-22.8%$7.69B$489.73M32.601,001
INSP
Inspire Medical Systems
2.9682 of 5 stars
$203.53
-3.1%
$345.08
+69.5%
+7.8%$5.97B$526.08M-141.34755Positive News

Related Companies and Tools

This page (NYSE:TFX) was last updated on 9/25/2023 by MarketBeat.com Staff

My Account -